Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $22.61B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: XPO stock price vs ALKS: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ALKS's multiple
Needs ALKS P/E.
Implied fair value · at XPO's multiple
Needs XPO P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: XPO FY 2025 (ended Dec 31, 2025) · ALKS FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 87% equity / 13% debt · EV / Revenue 3.15x · EV / EBITDA 35.51x
Capital structure 96% equity / 4% debt · EV / Revenue 5.19x · EV / EBITDA 23.76x
XPO carries the larger enterprise value at $25.71B against $7.66B; XPO trades on the lower EV / Revenue multiple (3.15x vs 5.19x); ALKS on the lower EV / EBITDA (23.76x vs 35.51x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
XPO, Inc. · implied price per share
Bear
-$17.35
Base
-$15.65
Bull
-$13.36
Alkermes plc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.83x
0.17x
Net debt / EBITDA
Leverage against operating earnings
4.28x
-0.22x
Cash and equivalents
Liquid reserves on the balance sheet
$310.00M
$388.57M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
C. H. ROBINSON WORLDWIDE, INC.
XPO vs CHRW
Hub Group, Inc.
XPO vs HUBG
SAIA INC
XPO vs SAIA
OLD DOMINION FREIGHT LINE, INC.
XPO vs ODFL
FEDEX CORP
XPO vs FDX
UNITED PARCEL SERVICE INC
XPO vs UPS
Jazz Pharmaceuticals plc
XPO vs JAZZ
SUPERNUS PHARMACEUTICALS, INC.
XPO vs SUPN
Amneal Pharmaceuticals, Inc.
XPO vs AMRX
$3.41B
$317.13M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
